Cargando…

Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line

Monoclonal antibodies (mAbs) are widely utilized as therapeutic drugs for various diseases, such as cancer, autoimmune diseases, and infectious diseases. Using the avian-derived B cell line DT40, we previously developed an antibody display technology, namely, the ADLib system, which rapidly generate...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Hidetaka, Masuda, Hitomi, Asagoshi, Kenjiro, Uchiki, Tomoaki, Kawata, Shigehisa, Sasaki, Goh, Yabuki, Takashi, Miyai, Shunsuke, Takahashi, Naoki, Hashimoto, Shu-ichi, Sawada, Atsushi, Takaiwa, Aki, Koyama, Chika, Tamai, Kanako, Kurosawa, Kohei, Lin, Ke-Yi, Ohta, Kunihiro, Nakazaki, Yukoh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166883/
https://www.ncbi.nlm.nih.gov/pubmed/32457406
http://dx.doi.org/10.1038/s41423-020-0440-9
_version_ 1783701588793098240
author Seo, Hidetaka
Masuda, Hitomi
Asagoshi, Kenjiro
Uchiki, Tomoaki
Kawata, Shigehisa
Sasaki, Goh
Yabuki, Takashi
Miyai, Shunsuke
Takahashi, Naoki
Hashimoto, Shu-ichi
Sawada, Atsushi
Takaiwa, Aki
Koyama, Chika
Tamai, Kanako
Kurosawa, Kohei
Lin, Ke-Yi
Ohta, Kunihiro
Nakazaki, Yukoh
author_facet Seo, Hidetaka
Masuda, Hitomi
Asagoshi, Kenjiro
Uchiki, Tomoaki
Kawata, Shigehisa
Sasaki, Goh
Yabuki, Takashi
Miyai, Shunsuke
Takahashi, Naoki
Hashimoto, Shu-ichi
Sawada, Atsushi
Takaiwa, Aki
Koyama, Chika
Tamai, Kanako
Kurosawa, Kohei
Lin, Ke-Yi
Ohta, Kunihiro
Nakazaki, Yukoh
author_sort Seo, Hidetaka
collection PubMed
description Monoclonal antibodies (mAbs) are widely utilized as therapeutic drugs for various diseases, such as cancer, autoimmune diseases, and infectious diseases. Using the avian-derived B cell line DT40, we previously developed an antibody display technology, namely, the ADLib system, which rapidly generates antigen-specific mAbs. Here, we report the development of a human version of the ADLib system and showcase the streamlined generation and optimization of functional human mAbs. Tailored libraries were first constructed by replacing endogenous immunoglobulin genes with designed human counterparts. From these libraries, clones producing full-length human IgGs against distinct antigens can be isolated, as exemplified by the selection of antagonistic mAbs. Taking advantage of avian biology, effective affinity maturation was achieved in a straightforward manner by seamless diversification of the parental clones into secondary libraries followed by single-cell sorting, quickly affording mAbs with improved affinities and functionalities. Collectively, we demonstrate that the human ADLib system could serve as an integrative platform with unique diversity for rapid de novo generation and optimization of therapeutic or diagnostic antibody leads. Furthermore, our results suggest that libraries can be constructed by introducing exogenous genes into DT40 cells, indicating that the ADLib system has the potential to be applied for the rapid and effective directed evolution and optimization of proteins in various fields beyond biomedicine.
format Online
Article
Text
id pubmed-8166883
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81668832021-06-07 Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line Seo, Hidetaka Masuda, Hitomi Asagoshi, Kenjiro Uchiki, Tomoaki Kawata, Shigehisa Sasaki, Goh Yabuki, Takashi Miyai, Shunsuke Takahashi, Naoki Hashimoto, Shu-ichi Sawada, Atsushi Takaiwa, Aki Koyama, Chika Tamai, Kanako Kurosawa, Kohei Lin, Ke-Yi Ohta, Kunihiro Nakazaki, Yukoh Cell Mol Immunol Article Monoclonal antibodies (mAbs) are widely utilized as therapeutic drugs for various diseases, such as cancer, autoimmune diseases, and infectious diseases. Using the avian-derived B cell line DT40, we previously developed an antibody display technology, namely, the ADLib system, which rapidly generates antigen-specific mAbs. Here, we report the development of a human version of the ADLib system and showcase the streamlined generation and optimization of functional human mAbs. Tailored libraries were first constructed by replacing endogenous immunoglobulin genes with designed human counterparts. From these libraries, clones producing full-length human IgGs against distinct antigens can be isolated, as exemplified by the selection of antagonistic mAbs. Taking advantage of avian biology, effective affinity maturation was achieved in a straightforward manner by seamless diversification of the parental clones into secondary libraries followed by single-cell sorting, quickly affording mAbs with improved affinities and functionalities. Collectively, we demonstrate that the human ADLib system could serve as an integrative platform with unique diversity for rapid de novo generation and optimization of therapeutic or diagnostic antibody leads. Furthermore, our results suggest that libraries can be constructed by introducing exogenous genes into DT40 cells, indicating that the ADLib system has the potential to be applied for the rapid and effective directed evolution and optimization of proteins in various fields beyond biomedicine. Nature Publishing Group UK 2020-05-26 2021-06 /pmc/articles/PMC8166883/ /pubmed/32457406 http://dx.doi.org/10.1038/s41423-020-0440-9 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Seo, Hidetaka
Masuda, Hitomi
Asagoshi, Kenjiro
Uchiki, Tomoaki
Kawata, Shigehisa
Sasaki, Goh
Yabuki, Takashi
Miyai, Shunsuke
Takahashi, Naoki
Hashimoto, Shu-ichi
Sawada, Atsushi
Takaiwa, Aki
Koyama, Chika
Tamai, Kanako
Kurosawa, Kohei
Lin, Ke-Yi
Ohta, Kunihiro
Nakazaki, Yukoh
Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line
title Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line
title_full Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line
title_fullStr Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line
title_full_unstemmed Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line
title_short Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line
title_sort streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a b cell line
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166883/
https://www.ncbi.nlm.nih.gov/pubmed/32457406
http://dx.doi.org/10.1038/s41423-020-0440-9
work_keys_str_mv AT seohidetaka streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT masudahitomi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT asagoshikenjiro streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT uchikitomoaki streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT kawatashigehisa streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT sasakigoh streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT yabukitakashi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT miyaishunsuke streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT takahashinaoki streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT hashimotoshuichi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT sawadaatsushi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT takaiwaaki streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT koyamachika streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT tamaikanako streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT kurosawakohei streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT linkeyi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT ohtakunihiro streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline
AT nakazakiyukoh streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline